Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
, , , y
18 sept 2017
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 18 sept 2017
Páginas: 455 - 462
Recibido: 14 feb 2017
Aceptado: 18 ago 2017
DOI: https://doi.org/10.1515/raon-2017-0040
Palabras clave
© 2017 Barbara Faganel Kotnik, Janez Jazbec, Petra Bohanec Grabar, Cristina Rodriguez-Antona, Vita Dolzan
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Kotnik, Barbara Faganel
Department of Oncology and Haematology, University Children’s Hospital, University Medical Centre LjubljanaLjubljana, Slovenia
Jazbec, Janez
Department of Oncology and Haematology, University Children’s Hospital, University Medical Centre LjubljanaLjubljana, Slovenia
Grabar, Petra Bohanec
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Rodriguez-Antona, Cristina
Hereditary Endocrine Cancer Group Human Cancer Genetics Programme, Spanish National Cancer Research CentreMadrid, Spain
Dolzan, Vita
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia